1. Academic Validation
  2. Delineating, Imaging, and Assessing Pulmonary Fibrosis Remodeling via Collagen Hybridization

Delineating, Imaging, and Assessing Pulmonary Fibrosis Remodeling via Collagen Hybridization

  • ACS Nano. 2024 Oct 15;18(41):27997-28011. doi: 10.1021/acsnano.4c06139.
Jie Zhao 1 Wenjun Yu 1 2 Daoning Zhou 1 Yinghua Liu 1 Jingyue Wei 1 3 Lei Bi 1 Suwen Zhao 1 Jianzhong He 4 Jing Liu 5 Jin Su 6 Hongjun Jin 1 Ye Liu 4 Hong Shan 1 7 Man Li 1 3 Yaqin Zhang 2 Yang Li 1
Affiliations

Affiliations

  • 1 Guangdong Provincial Engineering Research Center of Molecular Imaging, Guangdong-Hong Kong-Macao University Joint Laboratory of Interventional Medicine, the Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, China.
  • 2 Department of Radiology, the Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, China.
  • 3 Biobank and Department of Information Technology and Data Center, the Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, China.
  • 4 Department of Pathology, the Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, China.
  • 5 Department of Pulmonary and Critical Care Medicine, the Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, China.
  • 6 State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Diseases, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510000, China.
  • 7 Department of Interventional Medicine, the Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, China.
Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive, life-threatening disease with no early detection, few treatments, and dismal outcomes. Although collagen overdeposition is a hallmark of lung fibrosis, current research mostly focuses on the cellular aspect, leaving collagen, particularly its dynamic remodeling (i.e., degradation and turnover), largely unexplored. Here, using a collagen hybridizing peptide (CHP) that specifically binds unfolded collagen chains, we reveal vast collagen denaturation in human IPF lungs and delineate the spatiotemporal progression of collagen denaturation three-dimensionally within fibrotic lungs in mice. Transcriptomic analyses support that lung collagen denaturation is strongly associated with up-regulated collagen catabolism in mice and patients. We thus show that CHP probing differentiates remodeling responses to antifibrotics and highlights the resolution of established fibrosis by agents up-regulating collagen catabolism. We further develop a radioactive CHP that detects fibrosis in vivo in mice as early as 7 days postlung-injury (Ashcroft score: 2-3) by positron emission tomography (PET) imaging and ex vivo in clinical lung specimens. These findings establish collagen denaturation as a promising marker of fibrotic remodeling for the investigation, diagnosis, and therapeutic development of pulmonary fibrosis.

Keywords

collagen catabolism; extracellular matrix remodeling; light sheet fluorescence microscopy; positron emission tomography imaging; pulmonary fibrosis; therapeutic assessment; transcriptomic analysis.

Figures
Products